All hormone receptors showed significantly lower expression levels in malignant mammary tumors compared to benign mammary tumors, mammary hyperplasia/dysplasia of FFPE samples, and non-neoplastic mammary tissue of fresh frozen samples (S1–S4 Figs). The gene discussed is NR4A1; the disease is breast cancer.